{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:47:51Z","timestamp":1771303671279,"version":"3.50.1"},"reference-count":24,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Context: Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) has been known as a rare disorder transmitted as an autosomal dominant trait, characterized by polyuria and polydipsia, and caused by deficient neurosecretion of arginine vasopressin precursor (AVP-NPII). We reported an ADNDI family with linkage to chromosome 20p13 but without mutations in the AVP-NPII gene.<\/jats:p>\n               <jats:p>Objective: The objective of this study was to identify the corresponding locus responsible for ADNDI in a family without AVP-NP II gene mutations.<\/jats:p>\n               <jats:p>Subjects and Methods: Two families with ADNDI were diagnosed by water deprivation test. The AVP-NPII gene was amplified by PCR and sequenced. A genomewide scan was performed in one family using 400 microsatellite markers covering 22 autosomes.<\/jats:p>\n               <jats:p>Results: A 3-bp deletion (1827\u20131829delAGG) of AVP-NPII gene was identified in the affected individuals in one family. Although no mutations could be detected in the coding, the promoter, and intronic regions of AVP-NPII gene in the other family, a maximum LOD score of 1.202999 (\u03b8 = 0.00) was obtained at marker D20S889 by genomewide scan, and a 7-cM interval on chromosome 20p13 was defined by fine mapping with markers D20S199\u2013D20S849. Furthermore, the intragenic region that regulates AVP-NPII and oxytocin expression as an enhancer element and the UBCE7IP5 gene that participates in prohormone degradation were sequenced. No alterations could be detected either.<\/jats:p>\n               <jats:p>Conclusion: The corresponding locus responsible for ADNDI is possibly heterogeneous regarding the slightly different clinical features in these two families.<\/jats:p>","DOI":"10.1210\/jc.2004-2000","type":"journal-article","created":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T06:50:02Z","timestamp":1120719002000},"page":"4388-4393","source":"Crossref","is-referenced-by-count":19,"title":["Autosomal Dominant Neurohypophyseal Diabetes Insipidus with Linkage to Chromosome 20p13 but without Mutations in the AVP-NPII Gene"],"prefix":"10.1210","volume":"90","author":[{"given":"Lei","family":"Ye","sequence":"first","affiliation":[{"name":"Shanghai Clinical Center for Endocrine and Metabolic Diseases (L.Y., X.L., Y.C., W.W., T.S., L.J., B.C., G.N.), Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Clinical Center for Endocrine and Metabolic Diseases (L.Y., X.L., Y.C., W.W., T.S., L.J., B.C., G.N.), Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, People\u2019s Republic of China"},{"name":"Division of Endocrine and Metabolic Diseases (X.L., G.N.), E-Institute of Shanghai Universities, Shanghai 200025, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Shanghai Clinical Center for Endocrine and Metabolic Diseases (L.Y., X.L., Y.C., W.W., T.S., L.J., B.C., G.N.), Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (H.S.), Inner Mongolia University for Nationalities Affiliated Hospital, Inner Mongolia 028000, Mongolia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Clinical Center for Endocrine and Metabolic Diseases (L.Y., X.L., Y.C., W.W., T.S., L.J., B.C., G.N.), Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingwei","family":"Su","sequence":"additional","affiliation":[{"name":"Shanghai Clinical Center for Endocrine and Metabolic Diseases (L.Y., X.L., Y.C., W.W., T.S., L.J., B.C., G.N.), Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Shanghai Clinical Center for Endocrine and Metabolic Diseases (L.Y., X.L., Y.C., W.W., T.S., L.J., B.C., G.N.), Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Cui","sequence":"additional","affiliation":[{"name":"Shanghai Clinical Center for Endocrine and Metabolic Diseases (L.Y., X.L., Y.C., W.W., T.S., L.J., B.C., G.N.), Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[{"name":"Shanghai Clinical Center for Endocrine and Metabolic Diseases (L.Y., X.L., Y.C., W.W., T.S., L.J., B.C., G.N.), Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, People\u2019s Republic of China"},{"name":"Division of Endocrine and Metabolic Diseases (X.L., G.N.), E-Institute of Shanghai Universities, Shanghai 200025, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071617392103800_R1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0889-8529(18)30031-8","article-title":"Diabetes insipidus.","volume":"24","author":"Robertson","year":"1995","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071617392103800_R2","first-page":"362","article-title":"Williams textbook of endocrinology","author":"Jackson","year":"1998","journal-title":"9th ed. Philadelphia: WB Saunders;"},{"key":"2020071617392103800_R3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1210\/jcem-70-3-752","article-title":"Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus.","volume":"70","author":"Repaske","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617392103800_R4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2265.2003.01834.x","article-title":"Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene.","volume":"59","author":"Elias","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617392103800_R5","first-page":"143","article-title":"A new missense mutation of the vasopressin-neurophysin II gene in a family with neurohypophyseal diabetes insipidus.","volume":"60","author":"Wolf","year":"2003","journal-title":"Horm Res"},{"key":"2020071617392103800_R6","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1210\/jcem.87.7.8677","article-title":"Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine (2) in the vasopressin moiety of the hormone precursor.","volume":"87","author":"Rittig","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617392103800_R7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-2002-29091","article-title":"Identification of a novel mutation in the arginine vasopressin-neurophysin II gene in familial central diabetes insipidus.","volume":"110","author":"Bullmann","year":"2002","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2020071617392103800_R8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1530\/eje.0.1460649","article-title":"Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysin II gene.","volume":"146","author":"Rutishauser","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2020071617392103800_R9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/mgme.2000.3117","article-title":"A missense mutation encoding Cys(67) \u2192 Gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus.","volume":"72","author":"DiMeglio","year":"2001","journal-title":"Mol Genet Metab"},{"key":"2020071617392103800_R10","first-page":"228","article-title":"Frohman","author":"Philip Felig, Lawrence","year":"2001","journal-title":"Endocrinology and metabolism. 4th ed. New York: McGraw-Hill;"},{"key":"2020071617392103800_R11","first-page":"600","article-title":"Glu-47, which forms a salt bridge between neurophysin-II and arginine vasopressin, is deleted in patients with familial central diabetes insipidus.","volume":"77","author":"Yuasa","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617392103800_R12","first-page":"107","article-title":"Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus.","volume":"58","author":"Rittig","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2020071617392103800_R13","first-page":"870","article-title":"Effects of aging on vasopressin production in a kindred with autosomal dominant neurohypophyseal diabetes insipidus due to the DeltaE47 neurophysin mutation.","volume":"87","author":"Mahoney","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617392103800_R14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0303-7207(00)00288-4","article-title":"A diabetes insipidus vasopressin prohormone altered outside the central core of neurophysin accumulates in the endoplasmic reticulum.","volume":"167","author":"Nijenhuis","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"2020071617392103800_R15","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.88.10.4240","article-title":"Crystal structure of a bovine neurophysin II dipeptide complex at 2.8 A determined from the single-wavelength anomalous scattering signal of an incorporated iodine atom.","volume":"88","author":"Chen","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071617392103800_R16","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1523\/JNEUROSCI.23-21-07801.2003","article-title":"Regulatory domains in the intergenic region of the oxytocin and vasopressin genes that control their hypothalamus-specific expression in vitro.","volume":"23","author":"Fields","year":"2003","journal-title":"J Neurosci"},{"key":"2020071617392103800_R17","doi-asserted-by":"crossref","first-page":"19617","DOI":"10.1074\/jbc.M100192200","article-title":"Interaction of the ring finger-related U-box motif of a nuclear dot protein with ubiquitin-conjugating enzymes.","volume":"276","author":"Pringa","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071617392103800_R18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1210\/jcem.83.2.4542","article-title":"Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: indications for a processing defect.","volume":"83","author":"Gabreels","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617392103800_R19","doi-asserted-by":"crossref","first-page":"E535","DOI":"10.1152\/ajpendo.00344.2003","article-title":"Regulation of vasopressin secretion by ETA and ETB receptors in compartmentalized rat hypothalamo-neurohypophysial explants","volume":"286","author":"Rossi","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071617392103800_R20","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1210\/endo.143.5.8804","article-title":"Role of ghrelin in the regulation of vasopressin release in conscious rats.","volume":"143","author":"Ishizaki","year":"2002","journal-title":"Endocrinology"},{"key":"2020071617392103800_R21","doi-asserted-by":"crossref","first-page":"10231","DOI":"10.1523\/JNEUROSCI.23-32-10231.2003","article-title":"Regulation of vasopressin gene expression by cAMP and glucocorticoids in parvocellular neurons of the paraventricular nucleus in rat hypothalamic organotypic cultures.","volume":"23","author":"Kuwahara","year":"2003","journal-title":"J Neurosci"},{"key":"2020071617392103800_R22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jnr.10529","article-title":"Monoaminergic control of vasopressin and VIP expression in the mouse suprachiasmatic nucleus.","volume":"71","author":"Vacher","year":"2003","journal-title":"J Neurosci Res"},{"key":"2020071617392103800_R23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1590\/S0100-879X2002000900011","article-title":"Nitrergic modulation of vasopressin, oxytocin and atrial natriuretic peptide secretion in response to sodium intake and hypertonic blood volume expansion.","volume":"35","author":"Ventura","year":"2002","journal-title":"Braz J Med Biol Res"},{"key":"2020071617392103800_R24","first-page":"51","article-title":"Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1\u2192Val in the signal peptide of the arginine vasopressin\/neurophysin II\/copeptin precursor.","volume":"82","author":"Repaske","year":"1997","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/90\/7\/4388\/10776878\/jcem4388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/90\/7\/4388\/10776878\/jcem4388.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:36:06Z","timestamp":1594956966000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/90\/7\/4388\/2837474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,1]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2004-2000","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,1]]}}}